SCHEMBL4828686

SCHEMBL4828686

C(=C(c1ccccc1)c1ccccc1)c1cccc(-c2ccccc2-c2c3ccccc3c(-c3ccccc3-c3cccc(C=C(c4ccccc4)c4ccccc4)c3)c3ccccc23)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.41
CYP19A1 P11511 2/20 0.41
CYP11B2 P19099 2/20 0.41
PTGS2 P35354 2/20 0.36
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM1A O60341 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
NAT1 P18440 1/20 0.34
AKR1C1 Q04828 1/20 0.34
CYP2D6 P10635 1/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PTGER1 P34995 1/20 0.32
ASH1L Q9NR48 1/20 0.32
GPR84 Q9NQS5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14510113 0.86 KDM4E (0.38) ESR1CYP19A1CYP11B2MEN1ALDH1A1
SCHEMBL4828680 0.83 TRIM24 (0.43) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL4828677 0.83 ESR1 (0.37) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL4827188 0.82 TRIM24 (0.42) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL3850146 0.81 ESR1 (0.43) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL4828755 0.79 ALDH1A1 (0.35) ESR1CYP19A1CYP11B2MEN1ALDH1A1
SCHEMBL5473713 0.78 CYP19A1 (0.41) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL13995067 0.78 CYP19A1 (0.36) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL4827308 0.77 ESR1 (0.39) ESR1CYP19A1CYP11B2PTGS2MEN1
SCHEMBL13697102 0.76 CYP19A1 (0.39) ESR1CYP19A1CYP11B2PTGS2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080193799-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-08-14 US disclosed
US-7361796-B2 Orangic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2008-04-22 US disclosed
US-7053255-B2 Substituted diphenylanthracene compounds for organic electroluminescence devices IDEMITSU KOSAN CO., LTD. (JP) 2006-05-30 US disclosed
US-20060083947-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2006-04-20 US disclosed
US-20040214035-A1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. 2004-10-28 US disclosed
EP-1333018-A1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO., LTD. (JP) 2003-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193799-A1 Organic electroluminescence device EED, KCNH2, DCX ESR1 333/4885CYP19A1 2017/4885CYP11B2 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.